ÂÜÀòÂÒÂ×

Qingzhou Ji currently serves as the Assistant Vice President of the Technical Platform at Porton Advanced, focusing on corporate strategy development for R&D and overseeing the Technical Platform groups. Additionally, Qingzhou Ji is a Visiting Professor of Practice at Xi'an Jiaotong-Liverpool University. Previous experience includes roles such as Senior Director at CARsgen Therapeutics, where responsibilities involved managing R&D in Immune Cell Therapy, and Senior Director of Strategy Research at GenScript, contributing to gene therapy initiatives. Qingzhou Ji also held positions at MilliporeSigma and Sigma-Aldrich, leading teams in Genome Editing and Epigenome Editing. A research fellow at Albert Einstein College of Medicine and a research associate at Howard Hughes Medical Institute further contributed to a strong foundation in biochemistry and molecular biology. Qingzhou Ji obtained a Ph.D. and B.S. in Biochemistry from Peking University.